Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Vision X

Explore full profile

Specialty contact lenses and vision care solutions

Zhuhai, ChinaFounded 2018Health Tech & Medtech
Valuation $500M–1B Last recorded · 2021
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Vision X and the history behind them.

About Vision X

VisionX, established in Shanghai in 2018, is a company focused on the vision care industry, led by a team of veterans with experience in ophthalmology and optometry. The company develops and commercializes a range of products aimed at improving eye health.

The company's product portfolio includes specialty items such as Ortho-K lenses, scleral lenses, and Rigid Gas Permeable (RGP) lenses under the brand name iComfit®. In 2021, the iComfit® RGP lens received NMPA approval and was commercially launched. This was followed in 2023 by the NMPA approval and launch of their iComfit® Scleral and Ortho-K lenses. VisionX has also expanded into specialty spectacle lenses and soft contact lenses.

VisionX operates on a business model that encompasses research, development, manufacturing, and commercialization of its vision care products. The company has established its own manufacturing sites for rigid lenses, lens care solutions, and diagnostic instruments. Its funding history includes an Angel round in 2019, a Series A in 2020, Series Pre-B and B in 2021, and a Series B+ round in 2022, backed by top-tier healthcare investors.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2018
Headquarters
Zhuhai, China
Open positions
None listed
Dealroom signal
55.1/100
Industry
Health
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Ophthalmology, Hard Tech, DT and LS, science-based
Technology
Deep Tech
Client focus
b2c
Links
Website

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing Sep 2021 $100M $400M Temasek · Green Pine Capital · HongShan · Lake Bleu Capital —
EARLY VCOther financing Jan 2021 $15M $60M Fosun RZ Capital · HongShan · Highlight Capital · YuanBio Venture Capital —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Vision X website traffic

Latest recorded traffic for Vision X is 1.6K monthly website visits, up 233.3% over the last three months.

Latest monthly visits1.6K 3-month web change+233.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A9 investors entered at this stage

  • Fosun RZ Capital
  • HongShan
  • Highlight Capital
  • YuanBio Venture Capital
  • Sherpa Venture Partners
  • Green Pine Capital
  • 3H Health Investment
  • Temasek
  • Lake Bleu Capital
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China · Zhuhai HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Vision X on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Vision X’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.